Moreover, it was reported that treatment of NF-κB inhibitor Xanthii fructus (XF) strongly suppressed IL-4, IL-1β, IFN-γ and TNF-α in AD-like skin lesions [45]. The gene discussed is NFKB1; the disease is Alzheimer disease.